Neuphoria Therapeutics Inc.
NEUP
Rangering i aksjer
#29120
Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing... Neuphoria Therapeutics, Inc. is a biotechnology company currently advancing treatments through clinical trials. Its core mission involves pioneering therapies specifically engineered to address the intricate requirements of individuals living with neuropsychiatric disorders. The company was established on December 23, 2024, and its main corporate offices are located in Burlington, Massachusetts.
Aksjekurs
$3.92
Sist synkronisert: 2026-07-31
Markedsverdi
$21.16M
Endring (1 dag)
-0.13%
Endring (1 år)
60,767.52%
Land
US
Handel Neuphoria Therapeutics Inc. (NEUP)
Kategori
Healthcare
Aksjeprishistorikk for Neuphoria Therapeutics Inc. (NEUP)
Høyeste sluttskurs: $0.01 den 2023-08-01
Laveste sluttskurs: $0.56 den 1999-12-01
Laveste sluttskurs: $0.56 den 1999-12-01
Aksjeprishistorikk for Neuphoria Therapeutics Inc. fra 1999 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2023 | -78.35% |
| 2022 | -97.66% |
| 2021 | 1,363.12% |
| 2020 | 63.69% |
| 2019 | -30.83% |
| 2018 | -71.66% |
| 2017 | 18.70% |
| 2016 | -12.16% |
| 2015 | -19.29% |
| 2014 | -47.97% |
| 2013 | 95.06% |
| 2012 | -36.40% |
| 2011 | -90.46% |
| 2010 | 1,655.11% |
| 2009 | 133.43% |
| 2008 | -61.74% |
| 2007 | 121.34% |
| 2006 | 1.97% |
| 2005 | -16.73% |
| 2004 | -11.05% |
| 2003 | -22.47% |
| 2002 | -28.01% |
| 2001 | -20.19% |
| 2000 | -11.88% |
| 1999 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $760.15 | 8.04% |
CH
|
